DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Michels S, Rosenfeld PJ, Puliafito CA. et al.
Systemic Bevacizumab (Avastin) for neovascular age-related macular degeneration. Twelve-week results of an uncontrolled open-label clinical study.
Ophthalmology 2005 (in press);
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.